Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1Breast 1

Conditions

Breast Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Sexual Dysfunction, Physiological 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Depression 1Carcinoma, Ovarian Epithelial 1Anxiety Disorders 1

Interventions

Therapeutics 21Psychiatric Rehabilitation 20Surveys and Questionnaires 7Early Intervention, Educational 6Counseling 6Yoga 5Psychosocial Intervention 5Cognitive Behavioral Therapy 5Behavior Therapy 5Mindfulness 4Ketamine 4Exercise 4Escitalopram 4Acupuncture Therapy 4Saline Solution 3Psilocybin 3Mindfulness-Based Stress Reduction 3Mindfulness-Based Cognitive Therapy 3Methods 3Exercise Therapy 3Control Groups 3Citalopram 3Chemotherapy, Adjuvant 3Sugars 2Sertraline 2Palliative Care 2Observation 2Niacin 2Mental Status and Dementia Tests 2Interviews as Topic 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Depression × Dehydroepiandrosterone × Clear all
NCT01376349 2019-02-07

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Alliance for Clinical Trials in Oncology

Phase 3 Completed
464 enrolled 8 charts
BreastGynecologicOther

Carcinoma, Ovarian Epithelial, Anxiety Disorders, Breast Neoplasms, Uterine Cervical Neoplasms, Depression, Fallopian Tube Neoplasms, Sexual Dysfunction, Physiological, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡